Icon

Aptensio XR - (10,15,20,30,40,50,60 mg; Capsule, Extended Release)

Methylphenidate Hydrochloride Rhodes Pharma
10,15,20,30,40,50,60 mg; Capsule, Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)
Yes
******* ** *** ***** ** **** **** ** *** ********* ** **** ******* '***, ’***, ’***, ’***, ‘***, *** ’*** *** ******** ** *** **, ****. ****** ****** ***** * **** ******* ******* ** ******** ***** ** **. ****** *** ****** ** ** ****** ****, ********** *** ********* **** ******* ***** *** ***** ** ********* *** *** ***** *** ** ****** ** ** ** * ****** ****** *** **, **** ** ** ** *** **** ****** ********** *** ****.
Aptensio XR Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8
******* ******* ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ *** *** *, **** ******* ******** ******** ** *** **, ****
  1. *** **, **** : ******* ******** ****** ****** ***** *** **** ** **** ******* '***, ’***, ’***, ’***, ‘***, *** ’*** *** ******** ** *** **, ****.
  2. *** *, **** : ****** ***** * **** ******* ******* ** ******** ***** ** **.
  3. *** **, **** : ********** ********* **** ******* *** *** *** ******* ** ***** *.*. ******* '***, ’***, ’***, ’***, ‘***, *** ’*** *** ******** ** *** **, ****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.